Article
Bristol Myers drug fails to meet main goal of COVID study
Rating:
0.0
Views:
61
Likes:
1
Library:
1
Bristol Myers Squibb said on Thursday its drug Orencia did not show statistically significant results in speeding up recovery in COVID-19 patients versus a placebo in a late-stage study.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value